Now, where the hell did this come from? Of course, from the

New Post Public Reply Private Reply Replies (0) Message Board
WBeacham
431
Now, where the hell did this come from? Of course, from the o.b. thx mucho (again!) to Gimmee Greenbacks, D.D.H.E. (Due Diligence Hound dog Emeritus), post #292373.

https://www.sghealthcarepartners.com/copy-of-pain-dx

No, seriously, where the hell did this come from? Like a 'bolt from the blue' we are plainly visible and well presented. In less than 2 min you understand what RecoveryRx is, how it works, and how you can use it. Done. This is excellent. I am so happy to see this kind of exposure, in the USA !!! Is it safe to say that BIEL has a signed agreement w/ Shephard Group Healthcare Partners?

From the linked page:
Quote:
Here are a few facts to consider when it comes to postoperative pain…

1) Surgical procedures involve severing of nerve tissue, leading to alterations in pain processing1 and induction of central sensitization.

2) Inadequately controlled postoperative pain can lead to chronic pain. The incidence of chronic postoperative pain is 10-30%, depending on the surgery.

3) More than 50% of patients report inadequate postoperative pain relief, with >80% indicating that the pain is moderate to severe.

4) Pharmacotherapy (NSAIDs and Opioids) is effective, but incomplete, and poorly addresses central sensitization.

https://www.sghealthcarepartners.com/copy-of-join-the-team

If we have SGHP on board w/ RecoveryRx in the USA are there others? They have several openings for Clinical Practice Consultant. See the second link above. So, I would guess we don't have an exclusive agreement w/ them. But if we have this business relationship and we are only hearing about this via a poster (a certified D.D.H.E.) then might we have others waiting to be discovered?

The org seems to be young and aggressive in building out their business. On the 'Home' page their motto is "Superior Outcomes Through Superior Science" and the bulleted points are (comments are mine):

** Obtain Better Outcomes (actual pain relief)
** Mitigate Risk (no more legal issues w/ opioids)
** Increase Practice Revenue (patients will prefer & request it)

And that is precisely what RecoveryRx does. Very exciting discovery. Thanks again to Gimmee Greenbacks for sharing.

In the US there are between 40-50 million surgeries annually and about 20-30 million in Europe. Let's say 1% (US mkt.) require one RecoveryRx to mitigate post-operative pain and ASSUME a $10 profit on each item. That translates to $4,000,000; Four Million dollars. That is w/ 1% in the US alone. Not including Canada, Mexico, Spain (!), the rest of Europe, and all of Asia. Also, not including online sales, in-store sales and increased awareness leading to critical mass adoption. Somewhere in this mix must be insurance codes. What else is on the horizon? I wait.

I wonder what the B&Bs will do to mangle and misinterpret this?

later, WBeacham

BioElectronics Corporation (BIEL) Stock Research Links

BIEL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Supply Maverick Simplifies Global Shipping Processes

Updated Category News Views 6

Paving the Way for Seamless International Shipping Supply Maverick's got a new mantra, folks: simplicity. They're slicing through the mess of international shipping and bringing some much-needed clarity for customers in Canada, Australia, and New Zealand. It’s about time someone shook up the logistics playbook. The Nuts and Bolts of the New Shipping System Imagine being...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 0

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
Jari Spirits Set to Shake Up U.S. Market After Big Wins

Updated Category News Views 4

Korean Spirits Jari Eyes U.S. Market Entry Some stories just have that perfect 'right time, right place' vibe, and CJ Foods' recent splash with their Korean spirits brand jari is one of them. Buckle up, because this one's about a Korean distilling sensation gearing up to hit American shores with a bang. Accolades Pave the Path Jari, the premium Korean distilled spirits...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 0

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
DCM Services Teams with AKUVO to Boost Estate Recoveries

Updated Category News Views 14

Revolutionizing Estate Recovery Practices Here's the scoop: DCM Services (DCMS), that big shot in estate account resolution, is hooking up with AKUVO to shake up how credit unions handle estate recoveries. This alliance is a clear nod to modernizing a process stuck in the past. Let’s face it, handling decedent and probate accounts is no cakewalk, and traditional methods...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 0

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 0

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 0

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
Melissa Rivers Brings Her Wit Back to Emmys Carpet

Updated Category News Views 12

They say you can never go home again, but don't tell that to Melissa Rivers. Rolling the dice on nostalgia and kicking off a new chapter, she's waltzing back to the Emmys red carpet for the first time in nearly 20 years. Alright, what's in it for investors? Not much—unless you're looking to invest in nostalgia. But there's something here about legacy, reinvention, and...

Continue Reading
Modeling and Mental Health Join Forces for Wellness

Updated Category News Views 5

A Fresh Alliance for Mental Wellness in Modeling Alright, let's shine a spotlight on a significant step in the modeling industry, a place typically less vocal about mental health. In a move that feels long overdue, Brain-Body Therapy and Mother Model Management have joined forces, marking the beginning of a collaborative effort to propel mental wellness to the forefront...

Continue Reading

Top 5 Most Recently Viewed Articles

Beko's Smart Living Index Highlights the Shift Towards Sustainability

Updated Category News Views 106

Embracing the Shift in Sustainable Living Beko, a renowned leader in home appliances, recently unveiled its Smart Living Index (SLI), shedding light on how economic pressures are propelling households toward sustainable living choices. This extensive survey captured the changing perspectives of consumers globally regarding sustainability and energy efficiency. Insights...

Continue Reading
Admiral Markets AS Reports Strong 2024 Financial Results

Updated Category News Views 122

Admiral Markets AS Reports Strong Performance in 2024 Admiral Markets AS 2024 Financial Highlights In a year characterized by low volatility in financial markets, Admiral Markets AS has demonstrated impressive resilience. The company has successfully boosted its trading revenues and achieved a positive EBITDA, thanks to its rigorous cost control measures. This...

Continue Reading
E2open Earns Recognition as Leader in Supply Chain Planning

Updated Category News Views 98

E2open Recognized as a Leader in Supply Chain Planning E2open Parent Holdings, Inc. (NYSE: ETWO), a leading connected supply chain SaaS platform, has received significant acknowledgment by the IDC MarketScape. The company has been named a Leader in various IDC MarketScape reports, including the Worldwide Supply Chain Planning Overall 2024 Vendor Assessment, as well as...

Continue Reading
Katherine Aird, Ph.D., Joins Wistar's Caplan Cancer Center

Updated Category News Views 159

Exciting Addition to Wistar Institute's Research Team The Wistar Institute, a leader in innovative biomedical research, has made a significant announcement regarding their team structure. The esteemed institution has welcomed Katherine Aird, Ph.D. as the new co-leader and professor within the Molecular and Cellular Oncogenesis Program at the Ellen and Ronald Caplan Cancer...

Continue Reading
Challenges Ahead for Tesla: A Look at Future Quarters

Updated Category News Views 263

Challenges Ahead for Tesla Tesla Inc. (NASDAQ: TSLA), led by CEO Elon Musk, is bracing for a challenging phase as the availability of federal EV credits diminishes and tariff-related pressures escalate. The Impact of EV Credit Expiration During a recent earnings call, Musk indicated that the company might face a few difficult quarters due to the expiration of a...

Continue Reading